AGL 5.50 Decreased By ▼ -0.10 (-1.79%)
ANL 8.62 Decreased By ▼ -0.28 (-3.15%)
AVN 75.84 Decreased By ▼ -1.14 (-1.48%)
BOP 5.18 Decreased By ▼ -0.07 (-1.33%)
CNERGY 4.51 Decreased By ▼ -0.14 (-3.01%)
EFERT 81.09 Decreased By ▼ -0.13 (-0.16%)
EPCL 49.94 Decreased By ▼ -0.09 (-0.18%)
FCCL 12.51 Decreased By ▼ -0.65 (-4.94%)
FFL 5.52 Decreased By ▼ -0.18 (-3.16%)
FLYNG 6.87 Decreased By ▼ -0.23 (-3.24%)
FNEL 4.63 Decreased By ▼ -0.13 (-2.73%)
GGGL 8.53 Decreased By ▼ -0.27 (-3.07%)
GGL 14.22 Decreased By ▼ -0.38 (-2.6%)
HUMNL 5.58 Decreased By ▼ -0.09 (-1.59%)
KEL 2.62 Decreased By ▼ -0.01 (-0.38%)
LOTCHEM 27.98 Decreased By ▼ -0.67 (-2.34%)
MLCF 23.68 Decreased By ▼ -1.01 (-4.09%)
OGDC 71.64 Decreased By ▼ -0.87 (-1.2%)
PAEL 15.33 Decreased By ▼ -0.04 (-0.26%)
PIBTL 4.87 Decreased By ▼ -0.11 (-2.21%)
PRL 15.80 Decreased By ▼ -0.40 (-2.47%)
SILK 1.04 Decreased By ▼ -0.03 (-2.8%)
TELE 8.92 Decreased By ▼ -0.28 (-3.04%)
TPL 7.04 Decreased By ▼ -0.21 (-2.9%)
TPLP 18.31 Decreased By ▼ -0.39 (-2.09%)
TREET 21.03 Decreased By ▼ -0.67 (-3.09%)
TRG 134.51 Decreased By ▼ -2.04 (-1.49%)
UNITY 16.57 Decreased By ▼ -0.45 (-2.64%)
WAVES 9.34 Decreased By ▼ -0.55 (-5.56%)
WTL 1.36 Decreased By ▼ -0.05 (-3.55%)
BR100 4,155 Decreased By -70.3 (-1.66%)
BR30 15,289 Decreased By -229.2 (-1.48%)
KSE100 41,613 Decreased By -537.4 (-1.28%)
KSE30 15,360 Decreased By -228.1 (-1.46%)
Follow us

LONDON: London’s FTSE ended higher on Monday, aided by healthcare stocks as GlaxoSmithKline jumped after rejecting a 50-billion-pound buyout offer for its consumer arm from Unilever, while energy and mining stocks also provided support.

The blue-chip FTSE 100 index gained 0.9% to record its highest closing in nearly two years, with miner Glencore and energy majors BP and Royal Dutch Shell among the biggest boosts to the index. GlaxoSmithKline jumped 4.1% after it said over the weekend that it had rejected Unilever’s offer for its consumer goods arm and would stick to its plan of spinning off the unit.

Unilever shares dropped 7.0% and were the worst performer on the index. A report said the company was in talks with banks for additional financing to make a potential sweetened offer.

“Paying 50 billion pounds for a business that sells pain relief products and toothpastes comes across as a risky bet and while there appears to be universal consensus that Unilever needs to shake up its business ... the price tag for doing so seems a little on the rich side,” CMC Markets analyst Michael Hewson said.

Analysts at Barclays said that Unilever’s offer and the ensuing valuations are very complex to execute in normal times, let alone in the middle of a global pandemic.

The domestically focussed mid-cap index rose 0.6%.

Homebuilders gained 1.0% after a survey showed asking prices for British homes rose by the most in annual terms in nearly six years in early 2022.

Taylor Wimpey Plc, the UK’s third-largest house builder, added 4.2% after saying it expected annual results in line with its forecasts. Meanwhile, Clinigen Group Plc dropped 0.8% after agreeing to a sweetened takeover offer by UK-based private equity firm Triton that valued the pharmaceutical services firm at about 1.3 billion pounds ($1.78 billion).

Comments

Comments are closed.

FTSE 100 hits two-year high as GSK boosts

Stocks fall on noisy IMF humdrum

KP asks Wapda to pay Rs21bn

Afghan suppliers: Coal importers making ‘informal’ payments

Govt debt stocks hit historic high of Rs50.152trn

Petrol, diesel and LNG at discounted rates: Russian ministers due next month

Revolving fund account for CPEC IPPs approved: ECC allows import of 0.583MTs of wheat

Payables/receivables: Govt offered to seek resolution of dispute thru ICA, KE CEO tells Senate panel

Auditors’ appointment: SECP decides to take risk-based approach

New estimates place flood losses at $46bn

Afghanistan arrests ‘foreign IS member’ for embassy attack